Capital Advisors Ltd’s ResMed RMD Stock Holding History

Capital Advisors Ltd’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$53K	Buy	239 +33	+16%	+$7.2K	0.01%	504
2026 Q2	$40K	Buy	206 +2	+1%	+$415	﹤0.01%	554
2026 Q1	$46K	Hold	204	–	–	0.01%	517
2025 Q4	$49K	Hold	204	–	–	0.01%	482
2025 Q3	$56K	Hold	204	–	–	0.01%	453
2025 Q2	$53K	Hold	204	–	–	0.01%	460
2025 Q1	$46K	Hold	204	–	–	0.01%	473
2024 Q4	$47K	Hold	204	–	–	0.01%	467
2024 Q3	$50K	Sell	204 -8	-4%	-$1.79K	0.01%	455
2024 Q2	$41K	Buy	212 +7	+3%	+$1.42K	0.01%	479
2024 Q1	$41K	Buy	205 +5	+3%	+$916	0.01%	471
2023 Q4	$34K	Sell	200 -7	-3%	-$1.08K	﹤0.01%	482
2023 Q3	$31K	Buy	207 +42	+25%	+$7.59K	﹤0.01%	481
2023 Q2	$36K	Buy	165 +14	+9%	+$3.12K	0.01%	477
2023 Q1	$33K	Hold	151	–	–	0.01%	413
2022 Q4	$31K	Sell	151 -10	-6%	-$2.2K	0.01%	421
2022 Q3	$35K	Buy	161 +14	+10%	+$3.19K	0.01%	397
2022 Q2	$31K	Buy	147 +140	+2,000%	+$29.8K	0.01%	399
2022 Q1	$0	Sell	7 -142	-95%	-$34.3K	﹤0.01%	1164
2021 Q4	$39K	Buy	+149	New	+$38.7K	0.01%	376

Other funds holding RMD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Capital Advisors Ltd's RMD Position: Q3 2026 in Review

Capital Advisors Ltd increased its ResMed (RMD) stake by 16% in Q3 2026, buying an estimated $7.2K and bringing the position to 239 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #504.

Capital Advisors Ltd first reported a position in RMD in Q4 2021 and has held it in 20 quarters since. The position peaked at $56K in Q3 2025. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Capital Advisors Ltd held 239 shares of ResMed worth $53K as of Q3 2026.
Capital Advisors Ltd bought 33 ResMed shares in Q3 2026, an estimated $7.2K.
ResMed made up 0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #504 holding.
Capital Advisors Ltd first reported a position in ResMed in Q4 2021 and has held it in 20 quarters since.
Capital Advisors Ltd's ResMed position peaked at $56K in Q3 2025.
535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.